Differential Effect of Cytokines on CD4+ T‐Cell Activation, Metabolism, and Susceptibility to HIV‐1 Infection
Journal of Immunology Research · 2026
DOI: 10.1155/jimr/7633359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, 2026. Verfasst von Amal Elfidha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Viral Reservoirs and Immune Control Unit, Institut Pasteur, Université Paris Cité, Paris, France, u-paris.fr. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, HIV Infections, HIV-1, Cytokines. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH-National Institute of Diabetes and Digestive and Kidney Diseases, RHIVIERA program through ANRS and MSDAVENIR funds.
Abstract (Originalsprache)
HIV‐1 reservoirs are predominantly located in CD4+ T‐cells; however, not all CD4+ T‐cells contribute to the reservoir in the same way. Factors such as activation, differentiation, and cell metabolism have been proposed to determine the relative susceptibility of cells to HIV‐1 infection. HIV‐1 reservoirs are seeded early during the acute phase of infection, but the cell composition of these reservoirs evolves in the transition to chronic infection. This suggests that there are factors during the acute phase that may alter the intrinsic susceptibility of CD4+ T‐cells to HIV‐1. We investigated here the influence of common cytokines known to be secreted during the acute phase and to play a role in either T cell homeostasis or HIV‐1 infection on activation, differentiation, metabolic activity, and HIV‐1 susceptibility of CD4+ T‐cells. We show that the proinflammatory cytokines interleukin (IL)‐2, IL‐7, and IL‐15 induce cellular activation, differentiation to effector profile, increase in metabolic capacity, and HIV‐1 susceptibility. In contrast, IL‐21, another cytokine from the gamma‐chain (γc) family, showed opposing effects on the same parameters, including decreasing oxidative phosphorylation (OXPHOS) and HIV‐1 infection. We also show that IL‐10 and interferon (IFN)‐α are able to at least partially revert the cellular and metabolic changes induced by IL‐2 or IL‐7 and reduce the cells’ susceptibility to HIV‐1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Viral Reservoirs and Immune Control Unit, Institut Pasteur, Université Paris Cité, Paris, France, u-paris.fr.
- Unité HIV Inflammation et Persistance, Institut Pasteur, Université Paris Cité, Paris, France, u-paris.fr.
- Infectious Diseases Department, Hospital Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain, irycis.org.
- AIDS and HIV Infection Group, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain.
ORCID-Profile: Amal Elfidha, Erick De la Torre Tarazona, Caroline Passaes, José Alcamí, Asier Sáez-Cirión
Förderung
- NIDDK NIH HHS
- NIH-National Institute of Diabetes and Digestive and Kidney Diseases
- RHIVIERA program through ANRS and MSDAVENIR funds
- Institut Pasteur through the GPF LINMEC program
Zitieren
APA
Elfidha, A., De la Torre Tarazona, E., Passaes, C., Alcamí, J., Müller-Trutwin, M., & Sáez-Cirión, A. (2026). Differential Effect of Cytokines on CD4+ T‐Cell Activation, Metabolism, and Susceptibility to HIV‐1 Infection. Journal of Immunology Research. https://doi.org/10.1155/jimr/7633359
Vancouver
Elfidha A, De la Torre Tarazona E, Passaes C, Alcamí J, Müller-Trutwin M, Sáez-Cirión A. Differential Effect of Cytokines on CD4+ T‐Cell Activation, Metabolism, and Susceptibility to HIV‐1 Infection. Journal of Immunology Research. 2026. doi:10.1155/jimr/7633359
BibTeX
@article{Elfidha2026,
author = {Elfidha, Amal and De la Torre Tarazona, Erick and Passaes, Caroline and Alcamí, José and Müller-Trutwin, Michaela and Sáez-Cirión, Asier},
title = {Differential Effect of Cytokines on CD4+ T‐Cell Activation, Metabolism, and Susceptibility to HIV‐1 Infection},
journal = {Journal of Immunology Research},
year = {2026},
doi = {10.1155/jimr/7633359}
}
EUVIMED